Follow The Filings

WHWK Aadi Bioscience Inc.

Health Care, filed as AADI BIOSCIENCE INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by WHWK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All WHWK insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 14 sales to cover taxes, 6 stock grants, and 6 option exercises.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 5.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 8.01,9.01
SCHEDULE 13D/A —
SCHEDULE 13D/A —
8-K 1.01,3.02,7.01,9.01
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $24.35M $25.98M $7.14M
Gross profit * $21.54M $22.96M $6.38M
Gross margin * 88.5% 88.4% 89.4%
Net income -$65.76M -$63.69M -$20.6M
Net margin * -270.0% -245.1% -288.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $124.59M $61.29M $149.01M
Total non-current assets * $7.84M $9.03M $1.82M
Total assets $132.42M $70.32M $150.83M
Total current liabilities $26.4M $17.07M $14.52M
Total non-current liabilities * $833,000 $767,000 $0.00
Total equity $105.2M $52.48M $136.31M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$59.66M -$59.55M -$97.43M
Cash from investing $83.21M $25.2M $11.89M
Cash from financing $0.326M $0.13M $94.38M
Net change in cash $23.87M -$34.22M $8.83M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.